Vertex Pharmaceuticals Incorporated (VRTX)

185.83
1.30 0.68
NASDAQ
Prev Close 187.10
Day Low/High 184.78 / 188.53
52 Wk Low/High 185.32 / 280.99
Exchange NASDAQ
Shares Outstanding 259.43B
Market Cap 48.54B
P/E Ratio 23.27
Div & Yield N.A. (N.A)
Biotech's Next Big Thing: Vertex

Biotech's Next Big Thing: Vertex

TheStreet senior columnist Adam Feuerstein explains why Vertex Pharmaceuticals is the next big thing in biotech.

Still Plenty of Buying Interest

Still Plenty of Buying Interest

Action in individual stocks was impressive despite the struggling indices.

A One-Way Market

A One-Way Market

The action just keeps chugging higher.

Working for the Weekend

Working for the Weekend

I'm going to spend some time developing my watch list for next week.

Futures Point Higher; Boston Manhunt Plays Out

Futures Point Higher; Boston Manhunt Plays Out

US stock futures are up amid earnings from GE and IBM. TheStreet's Debra Borchardt details.

The Next Big Thing in Biotech: Earnings

The Next Big Thing in Biotech: Earnings

Adam Feuerstein, senior columnist for TheStreet, says biotech earnings are the next big thing to watch in biotech.

A Market in Limbo

A Market in Limbo

Traders are jockeying for position as we await the Fed, economic data and key earnings.

The Next Big Thing in Biotech: Dendreon/Vertex Earnings

The Next Big Thing in Biotech: Dendreon/Vertex Earnings

Senior columnist Adam Feuerstein says earnings from Dendreon and Vertex are the next big things in biotech.

The Next Big Thing In Biotech: Vertex

The Next Big Thing In Biotech: Vertex

Adam Feuerstein, Sr. Columnist for TheStreet, says Vertex Pharmaceuticals is the next big thing in biotech.

The 5 Dumbest Things on Wall Street: June 1

The 5 Dumbest Things on Wall Street: June 1

Here is this week's roundup of the dumbest actions on Wall Street.

Slow, but Positive

Slow, but Positive

The longer this action persists, the more anxious folks will be to put idle cash to work.

Biotech Breakout

Biotech Breakout

SPDR S&P Biotech ETF is likely to post new highs in the second quarter.

Daily Recap of the Charts, May 7

Daily Recap of the Charts, May 7

Evan Lazarus of T3Live review the day's market action and sets up your trading plan for the next session.

The Next Big Thing in Biotech: Pfizer

The Next Big Thing in Biotech: Pfizer

Senior columnist Adam Feuerstein says Pfizer is the next big thing in biotech.